Thorp Clay 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 20, 2022
Insider Transaction Report
Form 4
Thorp Clay
Director10% Owner
Transactions
- Award
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 totalExercise: $0.84Exp: 2032-05-18→ Common Stock (17,500 underlying) - Award
Restricted Stock Units
2022-05-19+3,750→ 3,750 total→ Common Stock (3,750 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
- [F3]The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.